Co-Founder
CurrentIn 2017, Mr. Lippert co-founded and is a Director of Permeatus, a pharmaceutical company initially focused on the topical treatment of Raynaud's.
Please complete the CAPTCHA to continue
@zars.com
✓
4 phones found area 801, 608, and 905
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Robert Lippert is listed as Co-Founder at Permeatus, based in Park City, Utah, United States. AeroLeads shows a work email signal at zars.com, phone signal with area code 801, 608, 905, and a matched LinkedIn profile for Robert Lippert.
Robert Lippert previously worked as President & CEO at Zars Pharma and President, CEO at Procertus Biopharm, Inc.. Robert Lippert holds Ba, Animal Biology from University Of Wisconsin-Madison.
This section adds company-level context without repeating Robert Lippert's masked contact details.
AeroLeads found 2 current-domain work email signals for Robert Lippert. Compare company email patterns before reaching out.
The more than 35 years of experience in the global biopharmaceutical industry has given me executive leadership and senior management skills as well as a deep functional understanding of corporate and business development, alliance management, product development, sales/marketing, and finance. My therapeutic areas of expertise include pain management, anesthesia, dermatology, rheumatology, oncology, and critical care medicine. In 2017, I co-founded Permeatus, a specialty pharma company focused on new treatments for Raynaud's Disease. Additionally, I have been a consultant for numerous pharma companies including Recros Medica, Crescita Therapeutics, Nuvo Research, Tapemark, Atterx, and Myoscience. These consulting activities included strategic planning, business development, corporate partnering, M&A/licensing, fund raising, valuation/financial analysis, and product development. Previously, I served as President, Chief Executive Officer at ZARS Pharma, a Salt Lake City based aesthetics and pain management company. As CEO, I oversaw two NDA submissions/approvals, filing of six INDs, closed over $30 MM in private funding from venture capital, and signed partnering deals that generated over $90 MM in milestone payments. One of the transaction that I was responsible for led to sale of ZARS Pharma to Nuvo Research.My career began at Ohmeda (acquired by Baxter) where I worked in the finance, sales, marketing, and business development departments. Later, I held several senior management positions including CEO of Procertus BioPharm, and Sr. Vice President at Medeva PLC (acquired by Celltech/UCB). In addition, I have also served on the Board of Directors of several life science/pharma companies including ZARS Pharma, ProCertus BioPharm, Permeatus, Kuda Therapeutics, and Tapemark.
Listed skills include Trading, Institutional, Sales, and Plc.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
San Diego, Ca
In 2017, Mr. Lippert co-founded and is a Director of Permeatus, a pharmaceutical company initially focused on the topical treatment of Raynaud's.
Salt Lake City, Ut
As CEO, oversaw two NDA submissions/approvals, filing of six INDs, closed over $30 MM in private funding from venture capital, and signed partnering deals that generated over $90 MM in milestone payments. Mr. Lippert oversaw transaction that led to sale of ZARS Pharma to Nuvo Research.
Authored Company’s business plan, recruited board members, executed licensing agreements, and coordinated all activities associated with a business start-up including fund raising.
Operational and P&L responsibility for Medeva’s hospital business, led several product launches and corporate licensing and product acquisition deals.
Led BD efforts for the Company. Ohmeda was a leader in the development and marketing of pain/anesthesia/peri-operative drugs. Acquired by Baxter in 1993.
Quick answers generated from the profile data available on this page.
Robert Lippert works for Permeatus.
Robert Lippert is listed as Co-Founder at Permeatus.
AeroLeads has found 2 work email signals at @zars.com for Robert Lippert at Permeatus.
AeroLeads has found 4 phone signal(s) with area code 801, 608, 905 for Robert Lippert at Permeatus.
Robert Lippert is based in Park City, Utah, United States while working with Permeatus.
Robert Lippert has worked for Permeatus, Zars Pharma, Procertus Biopharm, Inc., Medeva Plc, and Ohmeda (Baxter).
You can use AeroLeads to view verified contact signals for Robert Lippert at Permeatus, including work email, phone, and LinkedIn data when available.
Robert Lippert holds Ba, Animal Biology from University Of Wisconsin-Madison.
Robert Lippert is listed with skills including Trading, Institutional, Sales, and Plc.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Robert Lippert you were looking for.